Bridgeway Capital Management’s Epizyme, Inc EPZM Stock Holding History

Bridgeway Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-269,200	Closed	-$396K	–	1477
2022 Q2	$396K	Hold	269,200	–	–	0.01%	930
2022 Q1	$310K	Buy	+269,200	New	+$439K	0.01%	1070

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Bridgeway Capital Management's EPZM Position: Q3 2022 in Review

Bridgeway Capital Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 269,200 shares — an estimated $396K sold.

Bridgeway Capital Management first reported a position in EPZM in Q1 2022 and held it in 2 quarters. The position peaked at $396K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Bridgeway Capital Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Bridgeway Capital Management sold 269,200 Epizyme, Inc shares in Q3 2022, an estimated $396K.
Bridgeway Capital Management first reported a position in Epizyme, Inc in Q1 2022 and held it in 2 quarters.
Bridgeway Capital Management's Epizyme, Inc position peaked at $396K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.